Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00RQU
|
||||
Former ID |
DIB002320
|
||||
Drug Name |
Low molecular weight heparin
|
||||
Synonyms |
Low molecular weight heparin (solid oral, eligen); LMWH/SNAD (solid oral), Emisphere; Low molecular weight heparin (solid oral, eligen), Emisphere
|
||||
Indication | Thrombosis [ICD9: 437.6, 453, 671.5, 671.9; ICD10:I80-I82] | Phase 3 | [549903] | ||
Company |
Emisphere Technologies Inc
|
||||
Formula |
C26H42N2O37S5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Antithrombin-III | Target Info | Modulator | [544009] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.